Form 4: Lantheus Holdings Director Sam R. Leno Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4
Director Sam R. Leno exercised stock options and sold shares of Lantheus Holdings, Inc. (LNTH) common stock on March 4, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On March 4, 2024, Sam R. Leno, a director of Lantheus Holdings, Inc., executed stock options and sold shares of the company's common stock.
- The transactions were carried out under a Rule 10b5-1 trading plan adopted on November 29, 2023.
- Leno exercised options to acquire 2,045 shares at $16.30, 7,943 shares at $12.59, 8,333 shares at $6.00, and 4,068 shares at $64.20.
- Following the exercise of these options, Leno sold 5,025 shares at a weighted average price of $64.81 (ranging from $64.21 to $65.19) and 17,364 shares at a weighted average price of $65.60 (ranging from $65.21 to $66.14).
- After these transactions, Leno beneficially owns 57,937 shares of Lantheus Holdings, Inc.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity under a pre-arranged plan. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It's common for executives and directors to have pre-arranged trading plans (Rule 10b5-1) to avoid accusations of trading on inside information. The filing itself doesn't necessarily indicate a positive or negative outlook for the company.
Comparison to Industry Standards
- Insider trading activity is a common occurrence in publicly traded companies.
- Monitoring these transactions provides insights into management's perspective on the company's valuation and future prospects.
- Comparing Lantheus' insider trading activity to peers in the healthcare sector can reveal whether the level of insider buying or selling is typical or unusual.
Stakeholder Impact
- Shareholders may be interested in insider trading activity as an indicator of management's confidence in the company.
- However, transactions under a 10b5-1 plan are less likely to be indicative of current sentiment.
Key Dates
| Date | Description |
|---|---|
| November 29, 2023 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| March 4, 2024 | Date of the reported transactions (exercise of stock options and sale of shares) |
| March 6, 2024 | Date of signature for the Form 4 filing |
| May 6, 2023 | Expiration date of some of the options exercised |
| May 6, 2032 | Expiration date of some of the options exercised |
| May 16, 2024 | Expiration date of some of the options exercised |
| May 16, 2025 | Expiration date of some of the options exercised |
| June 16, 2014 | Start date of vesting for some of the options exercised |
| June 16, 2015 | Start date of vesting for some of the options exercised |
| June 25, 2016 | Start date of vesting for some of the options exercised |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.